DOCS Jan 2024 52.500 call
| Previous close | 0.6500 |
| Open | 0.6500 |
| Bid | 0.4000 |
| Ask | 0.7500 |
| Strike | 52.50 |
| Expiry date | 2024-01-19 |
| Day's range | 0.6500 - 0.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | 50 |
Motley Fool1 No-Brainer Stock to Buy With $100 Right Now
After doubling on its first day of trading and nearly doubling again in the next few months, shares of Doximity (NYSE: DOCS) have been on a steady march downward -- losing over 70% of its value from its all-time highs. Doximity's stock was caught in the all-too-common trap of initial public offering (IPO) hype, followed by a year or more of turbulence as the business settled into being a public company. This divergence between share price and operational performance leaves us wondering: Is now the time to buy Doximity at roughly 35% above its all-time lows?
ZacksDoximity (DOCS) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Business WireDoximity to Present at the William Blair 43rd Annual Growth Stock Conference
SAN FRANCISCO, May 23, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Dr. Nate Gross, co-founder and chief strategy officer, will present at the William Blair 43rd Annual Growth Stock Conference on Thursday, June 8, 2023 at 10:00 a.m. Central Time.
Motley Fool2 Growth Stocks Billionaires Keep Buying Hand Over Fist
The next time you go looking for the best possible growth stocks to buy, remember that you don't have to reinvent the wheel every time. Every three months, the U.S. Securities and Exchange Commission (SEC) makes just about anyone with over $100 million under management report their trading activities and the latest round of quarterly disclosures. Billionaire Steven Cohen and the fund he manages, Point72, bought nearly 675,000 shares of Doximity (NYSE: DOCS) in the first quarter.
Motley FoolSaaS Stocks Aren't Out of the Woods Just Yet
Mixed results from software platform providers show the jury's still out on the business model's viability.
ZacksDoximity (DOCS) Q4 Earnings and Revenues Top Estimates
Doximity (DOCS) delivered earnings and revenue surprises of 17.65% and 0.78%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireDoximity Announces New Integration with MEDITECH
SAN FRANCISCO, May 16, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced an integration with MEDITECH, one of the most widely used electronic health record (EHR) systems in the United States. The integration enables medical professionals to launch a Doximity Dialer voice or video telehealth visit directly from MEDITECH’s physician-facing native app, Expanse Now.
Business WireDoximity Announces Fourth Quarter and Fiscal Year 2023 Financial Results and New Senior Leadership Hires
SAN FRANCISCO, May 16, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2023 fourth quarter and fiscal year ended March 31, 2023. The company also announced the appointment of two new senior leadership members, Craig Overpeck as SVP of commercial operations and Ben Greenberg as SVP of commercial products.
ZacksNutex Health Inc. (NUTX) Reports Q1 Loss, Tops Revenue Estimates
Nutex Health Inc. (NUTX) delivered earnings and revenue surprises of 50% and 1.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Simply Wall St.Doximity, Inc. (NYSE:DOCS) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
It is hard to get excited after looking at Doximity's (NYSE:DOCS) recent performance, when its stock has declined 3.8...
ZacksCharles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates
Charles River (CRL) delivered earnings and revenue surprises of 7.34% and 4.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Motley Fool3 Best Stocks to Buy in May and Hold Forever
In need of healthcare exposure in your portfolio? Consider holding these three promising companies forever.
ZacksAgilon Health (AGL) Surpasses Q1 Earnings and Revenue Estimates
Agilon (AGL) delivered earnings and revenue surprises of 33.33% and 5.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireDoximity to Release Fiscal 2023 Fourth Quarter Results on May 16, 2023
SAN FRANCISCO, April 25, 2023--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter ended March 31, 2023 after market close on May 16, 2023. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
ZacksELV or DOCS: Which Is the Better Value Stock Right Now?
ELV vs. DOCS: Which Stock Is the Better Value Option?
- Business Wire
Doximity Releases New Study on Physician Compensation and Impact of Overwork and Economic Pressures
SAN FRANCISCO, March 23, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its annual Physician Compensation Report, revealing a slight decline of 2.4% in average pay for doctors in 2022. The report includes self-reported compensation data from over 190,000 U.S. doctors over six years and over 31,000 full-time physicians in the last year alone.
Business WireDoximity to Host Inaugural Investor Day June 6, 2023
SAN FRANCISCO, March 21, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it will host an Investor Day on Tuesday, June 6, 2023. The event will be held at the New York Stock Exchange in New York City from 10:30 a.m. to 1:30 p.m. Eastern Time.
Motley FoolWant $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait 10 Years
Patient investors who would like to see their investments rise 10x have some interesting options right now.
Motley Fool2 Top Growth Stocks to Buy Before the Next Bull Rally
Runaway inflation has been a serious problem for the global economy for nearly two years now. Interest rates that have risen sharply to combat inflation have already begun destabilizing financial systems, and nobody's really sure where we'll go from here.
Motley FoolCould AI Supercharge This Growth Stock?
Today, more than 80% of U.S. doctors already use Doximity. Could this new AI tool secure Doximity's leadership in the market -- and eventually supercharge the stock? Doximity generates revenue from pharmaceutical companies and hospital systems.
Motley FoolWant $1 Million in Retirement? Invest $200,000 in These 3 Stocks and Wait a Decade
A basket balanced evenly across these three businesses could jump-start your journey to becoming a millionaire.
Motley Fool2 Beaten-Down Growth Stocks to Buy on the Dip
For over a year now, growth stocks have been under a lot of pressure. For example, shares of Doximity (NYSE: DOCS) and SoFi Technologies (NASDAQ: SOFI) are down by more than half from their previous peaks. Shares of Doximity got way ahead of themselves when the all-digital bank made its stock market debut a few years ago.
Business WireDoximity to Participate in the Raymond James 44th Annual Institutional Investors Conference
SAN FRANCISCO, March 06, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 44th Annual Institutional Investors Conference on Wednesday, March 8, 2023, at 9:15 a.m. Eastern Time/6:15 a.m Pacific Time.
Motley FoolDoximity Stock: Bear vs. Bull
Doximity (NYSE: DOCS) has wowed investors with its solid list of customers, earnings growth, and top market position. After Doximity's June 2021 initial public offering, it climbed more than 90% in just a few months. Since, the stock performance hasn't reflected the company's successes.
Motley FoolDoximity Stock: Bull vs. Bear
The online networking platform for medical professionals went on to lose roughly two-thirds of its market cap. Here are the bull and bear arguments for Doximity stock. Probably the best reason to buy Doximity stock now is that the company has a tremendous growth opportunity ahead.
